Health Vita Therapeutics and I Peace announced a development program to generate iPS-derived differentiated cells for transplant therapy with an initial focus on FSHD (Facioscapulohumeral Muscular Dystrophy) using universal iPS cells July 10, 2025
Health Solenic Medical Appoints Medical Device Industry Veteran Bart Bandy as Chief Executive Officer July 10, 2025
Health MolecuLight Appoints Dr. Julia Wright as Chief Medical Officer to Accelerate Clinical Adoption July 10, 2025
Health Aurora Cannabis Inc. Announces Filing and Mailing of the Management Information Circular in Connection with the Annual General and Special Meeting of Shareholders July 10, 2025
Health Pioneering alliance between The Jackson Laboratory and The New York Stem Cell Foundation ushers in new era of predictive biomedical research July 10, 2025
Health Jungbunzlauer Showcases Bioavailable Mineral Innovations for Gummies at IFT FIRST 2025 July 10, 2025
Health XRP Healthcare Appoints Capital Markets Executive Anna Skowron as Chief Financial Officer Ahead of Proposed TSXV Listing July 9, 2025
Health First Patient Dosed in Phase 1/2 Clinical Study of Novel EGFR/HER3 Bispecific Antibody-Drug Conjugate AVZO-1418/DB-1418 July 9, 2025
Search
Health
July 10, 2025
July 10, 2025
July 10, 2025
July 10, 2025
July 10, 2025
July 10, 2025
July 9, 2025
July 9, 2025
July 9, 2025
July 9, 2025
